ATE137213T1 - Herstellung von fluoxetin und zwischenverbindungen - Google Patents

Herstellung von fluoxetin und zwischenverbindungen

Info

Publication number
ATE137213T1
ATE137213T1 AT92307190T AT92307190T ATE137213T1 AT E137213 T1 ATE137213 T1 AT E137213T1 AT 92307190 T AT92307190 T AT 92307190T AT 92307190 T AT92307190 T AT 92307190T AT E137213 T1 ATE137213 T1 AT E137213T1
Authority
AT
Austria
Prior art keywords
phenyl
fluoxetine
propanol
preparation
intermediate compounds
Prior art date
Application number
AT92307190T
Other languages
English (en)
Inventor
Eduard Schwartz
Joseph Kaspi
Zinovi Itov
Gidon Pilarski
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE137213T1 publication Critical patent/ATE137213T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92307190T 1991-08-27 1992-08-06 Herstellung von fluoxetin und zwischenverbindungen ATE137213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9931691A IL99316A (en) 1991-08-27 1991-08-27 Production of fluoxetine and new intermediates

Publications (1)

Publication Number Publication Date
ATE137213T1 true ATE137213T1 (de) 1996-05-15

Family

ID=11062843

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92307190T ATE137213T1 (de) 1991-08-27 1992-08-06 Herstellung von fluoxetin und zwischenverbindungen

Country Status (17)

Country Link
US (1) US5225585A (de)
EP (1) EP0529842B1 (de)
JP (1) JPH05213838A (de)
KR (1) KR0133051B1 (de)
AT (1) ATE137213T1 (de)
AU (1) AU645935B2 (de)
CA (1) CA2075869C (de)
DE (1) DE69210141T2 (de)
DK (1) DK0529842T3 (de)
ES (1) ES2089407T3 (de)
GR (1) GR3020540T3 (de)
HU (1) HU221626B1 (de)
IL (1) IL99316A (de)
MX (1) MX9204937A (de)
NZ (2) NZ243969A (de)
SI (1) SI9200186B (de)
ZA (1) ZA926068B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618968A (en) * 1993-02-05 1997-04-08 Pliva Farmaceutska Kemijska, Prehrambena I Kozmeticka Industrija, Dionicko Drustvo N-substituted derivatives of N-methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine and the procedure for their preparation
ES2103680B1 (es) * 1995-08-03 1998-04-01 Lilly Sa Procedimiento de preparacion de n-metil-3-fenil-3- (p-trifluorometilfenoxi)propilamina.
ES2103681B1 (es) * 1995-09-19 1998-04-01 Lilly Sa Procedimiento de preparacion de n-metil-3-fenil - (p-trifluorometilfenoxi) propilamina.
KR100390026B1 (ko) * 1996-06-27 2003-08-30 동아제약 주식회사 N-메틸-3-[(4-트리플로로메틸)펜옥시]-3-페닐프로필아민의제조방법
US6512010B1 (en) 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
HU226690B1 (en) * 1996-09-10 2009-06-29 Egis Gyogyszergyar Nyilvanosan Process for producing fluoxetin
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
US5892117A (en) * 1997-06-12 1999-04-06 Albemarle Corporation Preparation and uses of N-methylnitrone
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
US6355807B1 (en) 1999-08-24 2002-03-12 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
US6774243B2 (en) 1999-08-24 2004-08-10 Agouron Pharmaceuticals, Inc. Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
US20030064429A1 (en) * 1999-08-24 2003-04-03 Agouron Pharmaceuticals, Inc. Efficient methods for the preparation of rhinovirus protease inhibitors, key intermediates and a continuous membrane reactor useful for preparing the same
US6677485B2 (en) 1999-12-17 2004-01-13 Ranbaxy Laboratories Limited Process for the preparation of fluoxetine hydrochloride
US6313350B1 (en) 2001-01-31 2001-11-06 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310251B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6316672B1 (en) 2001-01-31 2001-11-13 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6258853B1 (en) 2001-01-31 2001-07-10 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310250B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form A of fluoxetine hydrochloride
EP1506965A4 (de) * 2002-05-20 2010-11-03 Mitsubishi Rayon Co Propanolaminderivate, verfahren zur herstellung von 3-n-methylamino-1-(2-thienyl)-1-propanolen und verfahren zur herstellung von propanolaminderivaten
US6846957B2 (en) 2002-11-22 2005-01-25 Board Of Regents, The University Of Texas System Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2006009884A1 (en) * 2004-06-17 2006-01-26 Dr. Reddy's Laboratories Ltd. 3-aryloxy-3-arylpropylamine synthesis
CN100430376C (zh) * 2006-11-03 2008-11-05 华东理工大学 一种制备n-甲基-3-苯基-3-羟基-丙胺的改进方法
CN102822161A (zh) 2010-03-24 2012-12-12 住友精化株式会社 制造光学活性n-单烷基-3-羟基-3-芳基丙胺化合物的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839423A (en) * 1973-12-19 1974-10-01 Lilly Co Eli Demethylation process
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4314081A (en) 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
DE2653766A1 (de) 1976-11-26 1978-06-01 Bayer Ag Substituierte benzolsulfonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS545223A (en) * 1977-06-15 1979-01-16 Caterpillar Mitsubishi Ltd Compound safety valve having functions of relief valve and make up valve
GB2060618A (en) 1979-09-14 1981-05-07 Wyeth John & Brother Ltd 3-Aryl-3-Aryloxypropylamines
IT1228209B (it) 1989-01-10 1991-06-05 Grato Magnone Procedimento per la preparazione di fluoxetina cloridrato.
FI81083C (fi) 1989-03-03 1990-09-10 Orion Yhtymae Oy Ett foerbaettrat foerfarande foer framstaellning av n-metyl-3-(p-trifluormetylfenoxi)-3-fenylpropylamin hydroklorid.

Also Published As

Publication number Publication date
NZ243969A (en) 1995-04-27
DE69210141T2 (de) 1996-10-31
KR930004257A (ko) 1993-03-22
HU221626B1 (hu) 2002-12-28
DE69210141D1 (de) 1996-05-30
AU645935B2 (en) 1994-01-27
KR0133051B1 (ko) 1998-04-13
ES2089407T3 (es) 1996-10-01
JPH05213838A (ja) 1993-08-24
IL99316A0 (en) 1992-07-15
MX9204937A (es) 1993-02-01
ZA926068B (en) 1993-04-28
SI9200186B (en) 2001-06-30
CA2075869C (en) 1997-10-14
NZ260857A (en) 1995-04-27
IL99316A (en) 1995-03-15
US5225585A (en) 1993-07-06
EP0529842A3 (en) 1993-05-19
EP0529842A2 (de) 1993-03-03
GR3020540T3 (en) 1996-10-31
AU2104792A (en) 1993-03-04
HU9202598D0 (en) 1992-10-28
HUT63144A (en) 1993-07-28
EP0529842B1 (de) 1996-04-24
SI9200186A (en) 1993-03-31
DK0529842T3 (da) 1996-05-13
CA2075869A1 (en) 1993-02-28

Similar Documents

Publication Publication Date Title
ATE137213T1 (de) Herstellung von fluoxetin und zwischenverbindungen
DK0469331T3 (da) Fremgangsmåde til fremstilling af organiske estere og amider
EA199600007A3 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
BR8705870A (pt) Processo para a producao de um uretano,composto e composicao curavel
ATE7292T1 (de) Verfahren zur herstellung von monochlormethylketonen.
ATE38220T1 (de) Herstellung von estern der 2-chlorpropionsaeure.
PT98700A (pt) Processo para a preparacao de acidos aminometanofosfonico e de acidos aminometil-fosfinicos
DE69114911D1 (de) Verfahren zur Herstellung von optisch-aktivem Zyklobutanon, ein Zwischenprodukt in der Synthese von optisch-aktiven Zyklobutanonnukleosiden.
FR2380271A1 (fr) Acides halogene-benzofuranone-carboxyliques utiles comme intermediaires de synthese
ATE82259T1 (de) Effiziente stereokonservative synthesen von 1substituierten (s)- und (r)-2aminomethylpyrrolidinen und zwischenprodukte dazu.
FI902590A0 (fi) Foerfarande foer framstaellning av 2-oxoindol-1-karboxamider.
GB1065124A (en) Phenyl-acetamido-propanediol derivatives
FR2428027A1 (fr) Nouveaux intermediaires de synthese perfluores et leur preparation
SU790614A1 (ru) Этиловый эфир 6-/2-хлор-фенокси/-сорбиновой кислоты, проявляющий гербицидную активность и способ его получения
FI862498L (fi) 1,3-substituoitu-(14-/7-metyyli-4,6-diokso-heksa-hydro-naft-8-yyli/etyyli)-16-suojattu hydroksi-14,15,17-tetrahydro-18H-pyran-18-onit ja niiden valmistus

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee